483 Amphastar Pharmaceuticals Mar 2017

483 Amphastar Pharmaceuticals Mar 2017

Amir Alavi FDA, Amanda Fyles FDA, Jennifer Gogley FDA, Carrie Hughes FDA, Sonya Karsik FDA, Walden Lee FDA, Jeffrey Raimondi FDA, Xiaohui Shen FDA, Marcus Yambot FDA$119.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observations (via FDA 483) on 31 Mar 2017.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 31 Mar 2017
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart